Anna-Riina Koskenniemi

- Doctoral Researcher,
Institute of Biomedicine (Faculty of Medicine)

arhuht@utu.fi

Histological tumor necrosis predicts decreased survival after neoadjuvant chemotherapy in head and neck squamous cell carcinoma (2025)
- Oral Oncology
Koskenniemi, A.R.; Huusko, T.; Routila, J.; Jalkanen, S.; Hollmén, M.; Vainio, P.; Ventelä, S.
Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth (2024)
- Cell Reports
Olotu, Opeyemi; Koskenniemi, Anna-Riina; Ma, Lin; Paramonov, Valeriy; Laasanen, Sini; Louramo, Elina; Bourgery, Matthieu; Lehtiniemi, Tiina; Laasanen, Samuli; Rivero-Müller, Adolfo; Löyttyniemi, Eliisa; Sahlgren, Cecilia; Westermarck, Jukka; Ventelä, Sami; Visakorpi, Tapio; Poutanen, Matti; Vainio, Paula; Mäkelä, Juho-Antti; Kotaja, Noora
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma (2024)
- Cancer Medicine
Luomala Lassi, Mattila Kalle, Vainio Paula, Nisén Harry, Pellinen Teijo, Lohi Jouni, Laajala Teemu D., Järvinen Petrus, Koskenniemi Anna-Riina, Jaakkola Panu, Mirtti Tuomas
Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer (2019)
- EJNMMI Research
Irena Saarinen, Ivan Jambor, Mai Kim, Anna Kuisma, Jukka Kemppainen, Harri Merisaari, Olli Eskola, Anna-Riina Koskenniemi, Ileana Montoya Perez, Peter Boström, Pekka Taimen, Heikki Minn
Kiveksen kehityshäiriö ja kivessyövän etiologia (2017)
- Duodecim
Koskenniemi Jaakko J, Koskenniemi Anna-Riina, Virtanen Helena E, Toppari Jorma